atsushi mitsuhashi

Research field (1)： Tumor biology

Research keywords (1)： lung cancer

Research theme for competitive and other funds (6)：

2022 - 2025 腫瘍内免疫療法を用いた新規複合がん免疫療法の効果規定因子を同定する試み
2022 - 2025 肺がん・中皮腫における新たな抗原提示細胞の同定から革新的複合がん免疫療法への展開
2021 - 2023 抗PD-L1抗体による腫瘍内血管制御を介した新規腫瘍抑制機序とバイオマーカー解析
2020 - 2023 Development of biomarkers related to drug resistance of angiogenesis inhibitors
2019 - 2022 Development of novel combination immunotherapy against lung cancer and mesothelioma: establishment of immunological basis for clinic

Show all

Papers (49)：

Yuki Tsukazaki, Hirokazu Ogino, Yoshio Okano, Soji Kakiuchi, Shoko Harada, Yuko Toyoda, Yugo Matsumura, Seiya Ichihara, Takeshi Imakura, Rikako Matsumoto, et al. Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer. International journal of clinical oncology. 2024
Kenya Miyamoto, Hirokazu Ogino, Takumi Kakimoto, Yugo Matsumura, Keiko Haji, Atsushi Mitsuhashi, Yutaka Morita, Yuki Tsukazaki, Yohei Yabuki, Ryohiko Ozaki, et al. Transformation of epidermal growth factor receptor mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: A case series and literature review. Respiratory medicine case reports. 2024. 51. 102076-102076
Hiroyuki Kozai, Hirokazu Ogino, Atsushi Mitsuhashi, Na Thi Nguyen, Yuki Tsukazaki, Yohei Yabuki, Ryohiko Ozaki, Hiroto Yoneda, Seidai Sato, Masaki Hanibuchi, et al. Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies. Thoracic cancer. 2023
Hiroto Yoneda, Atsushi Mitsuhashi, Aito Yoshida, Hirokazu Ogino, Satoshi Itakura, Na Thi Nguyen, Hiroshi Nokihara, Seidai Sato, Tsutomu Shinohara, Masaki Hanibuchi, et al. Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells. Cancer science. 2023
Yohei Yabuki, Masaki Hanibuchi, Eiji Takeuchi, Takashi Haku, Takanori Kanematsu, Naoki Nishimura, Yuko Toyoda, Atsushi Mitsuhashi, Kenji Otsuka, Seidai Sato, et al. A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer. Thoracic cancer. 2023. 14. 32. 3232-3239

ｍore...

MISC (17)：

ｍore...

Work history (5)：

2024 - 現在 JST創発的研究支援事業(JST-FOREST)創発研究者
2024 - 現在徳島大学大学院医歯薬学研究部呼吸器・膠原病内科学分野特任講師
2019 - 2024 徳島大学大学院医歯薬学研究部地域総合医療学分野特任助教
2018 - 2019 徳島大学病院呼吸器・膠原病内科医員
2016 - 2018 がん感染症センター都立駒込病院ジュニアレジデント

Awards (10)：

2023/12 - 徳島大学若手研究者学長表彰
2023/09 - 日本癌学会奨励賞
2023/06 - 日本がん分子標的治療学会研究奨励賞
2022/10 - Cancer Science Young Scientists Award 2022
2022/10 - 第81回日本癌学会学術総会若手研究者ポスター賞

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page